OLAJIRE KILANKO: Open Payments
NPI 1912384207 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 16 payments from 9 companies in 2025. Trend: 2023 $2,748 · 2024 $1,614 · 2025 $832
Food & beverage: $492Consulting: $240Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $281 |
| Geron Corporation | 1 | $126 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| ABBVIE INC. | 3 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Incyte Corporation | 1 | $20 |
| TAIHO ONCOLOGY, INC. | 1 | $20 |
| Kite Pharma, Inc. | 1 | $18 |
Products named: OJJAARA, RYTELO, Auvelity, REZUROCK, VENCLEXTA, EPKINLY, LUTATHERA, Fabhalta.
Industry payments across KS — which companies pay providers there.
